Breaking News

MedPharm Appoints Lynn Allen as CEO

Before joining MedPharm in 2019, Ms. Allen held leadership roles at DPT Labs and Jubilant.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MedPharm, a global topical and transdermal contract development and manufacturing organization (CDMO), has named Lynn Allen as chief executive officer (CEO), effective January 1, 2024. Ms. Allen has more than 25 years of experience in contract development and manufacturing services specific to topical, transdermal, and injectable delivery routes. Prior to joining MedPharm in 2019 as vice president of business development, Ms. Allen held a series of commercial leadership roles at DPT Laborator...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters